» Articles » PMID: 31069966

Association of the Prognostic Nutritional Index and Overall Survival in Patients with Colorectal Cancer: A STROBE Compliant Retrospective Cohort Study

Overview
Journal Cancer Med
Specialty Oncology
Date 2019 May 10
PMID 31069966
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The TNM classification does not completely reflect the prognosis of patients with colorectal cancer (CRC). Several clinical factors have been used to increase its prognostic value, but factors pertaining to the patient's immunonutritional status have not usually been addressed. The aim of this study is to evaluate the role of Prognostic nutritional index (PNI) and other well-known prognostic factors by multivariate analysis in a cohort of patients with CRC.

Methods: This is a retrospective cohort study of consecutive patients with CRC managed in a cancer center between January 1992 and December 2016. Cox's model was used to define the association of the PNI and other factors with Overall survival (OS).

Results: A total of 3301 patients were included: 47.7% were female and 52.3% were male, with a mean age of 58.7 years. By bivariate analysis, PNI was strongly associated with OS (Risk ratio [RR] 0.968, 95% Confidence interval [CI] 0.962-0.974; P < 0.001). On multivariate analysis, PNI was an independent explanatory variable (as continuous variable and as categorized variable; RR 0.732, 95% CI 0.611-0.878; RR 0.656, 95% CI 0.529-0.813 and RR 0.646, 95% CI 0.521-0.802, for quintiles 2, 3, and 4-5, respectively); a biological gradient effect was demonstrated. The final prognostic model included PNI, location of the neoplasia in the colorectum, basal hemoglobin, lymphocyte count, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, TNM stage, differentiation degree, R classification, and postoperative complications.

Conclusions: PNI is a significant and independent prognostic factor in patients with CRC. Its prognostic value adds precision to the TNM staging system including specific subgroups of patients with CRC; it should be evaluated in prospective clinical studies.

Citing Articles

Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study.

Wang Z, Zhao S, Zhang X, Mao X, Yang G, Yuan M PeerJ. 2024; 12:e18565.

PMID: 39624124 PMC: 11610478. DOI: 10.7717/peerj.18565.


Impact of preoperative inflammatory and nutritional markers on the prognosis of patients with peritoneal metastasis of colorectal cancer.

Wu Z, Lan B, Luo J, Ameti A, Wang H, Hu Q World J Gastrointest Oncol. 2024; 16(9):3865-3874.

PMID: 39350999 PMC: 11438771. DOI: 10.4251/wjgo.v16.i9.3865.


Preoperative serum cholinesterase as a prognostic factor in patients with colorectal cancer.

Nakamura K, Seishima R, Matsui S, Shigeta K, Okabayashi K, Kitagawa Y Ann Gastroenterol Surg. 2024; 8(4):650-659.

PMID: 38957551 PMC: 11216785. DOI: 10.1002/ags3.12794.


C-Reactive Protein/Albumin Ratio Is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients.

Bekki T, Shimomura M, Hattori M, Sato S, Watanabe A, Ishikawa S Ann Surg Oncol. 2024; 31(7):4812-4821.

PMID: 38280961 PMC: 11164793. DOI: 10.1245/s10434-024-14961-2.


Impact of prognostic nutritional index change on prognosis after colorectal cancer surgery under propofol or sevoflurane anesthesia.

Zhang L, Liu C, Yan Q, Cai X BMC Anesthesiol. 2024; 24(1):12.

PMID: 38172695 PMC: 10763006. DOI: 10.1186/s12871-023-02308-5.


References
1.
Suzuki Y, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kondo T . Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg. 2016; 267(3):527-531. DOI: 10.1097/SLA.0000000000002115. View

2.
Cao X, Zhao G, Yu T, An Q, Yang H, Xiao G . Preoperative Prognostic Nutritional Index Correlates with Severe Complications and Poor Survival in Patients with Colorectal Cancer Undergoing Curative Laparoscopic Surgery: A Retrospective Study in a Single Chinese Institution. Nutr Cancer. 2017; 69(3):454-463. DOI: 10.1080/01635581.2017.1285038. View

3.
Kattan M, Hess K, Amin M, Lu Y, Moons K, Gershenwald J . American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016; 66(5):370-4. PMC: 4955656. DOI: 10.3322/caac.21339. View

4.
Benson 3rd A, Venook A, Bekaii-Saab T, Chan E, Chen Y, Cooper H . Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015; 13(6):719-28. DOI: 10.6004/jnccn.2015.0087. View

5.
Tan D, Fu Y, Su Q, Wang H . Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2016; 95(24):e3837. PMC: 4998446. DOI: 10.1097/MD.0000000000003837. View